Company news

Quest PharmaTech Inc. news in 2024

Quest PharmaTech Inc.'s news releases, calls and decks from 2024, newest first.

View company

Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director

May 30, 2024

Quest Receives Cash Dividend Payment from OncoQuest

January 30, 2024

Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits

January 23, 2024